This archived selection pairs two retrospective cohorts with a single case report. Reading them together highlights why treatment comparisons and individual success stories require different levels of confidence.
1. Pyothorax: good selected-case outcomes do not prove one approach superior
Evidence: Retrospective review at two UK referral centres; 65 dogs and 38 cats; published October 13, 2026. Survival to discharge among medically managed animals was 35/40 dogs and 26/29 cats; surgical groups had 20/25 and 7/9 survivors. All 16 medically managed dogs receiving pleural lavage through thoracostomy tubes survived, compared with 8/11 without lavage in that subgroup.
What this means: Treatment was not randomized. The groups may differ in severity and indications, so these figures do not prove medical management is superior or that lavage caused improved survival. Recurrence and resistant isolates also matter when interpreting apparent initial success.
Study takeaway: Treat the findings as support for careful patient selection and further comparative research - not a universal “avoid surgery” rule. Bartlett et al., JSAP; primary abstract.
2. Acute feline CHF: improvement during combination treatment is not proof of drug efficacy
Evidence: Single-centre retrospective series of 71 cats receiving pimobendan and furosemide; published October 15, 2026. Respiratory rate and radiographic infiltrates improved within 24 hours, and 76% survived to discharge. Fifteen cats also received dobutamine; suspected adverse effects in seven of those cats responded to dose reduction or discontinuation.
What this means: Without an untreated comparator and with concurrent therapies, improvement cannot be attributed to pimobendan alone. The study does not establish a universal regimen for all cats with CHF. Findings about tolerability are not equivalent to proof of efficacy.
Study takeaway: When reading a treatment series, explicitly list the co-interventions and the missing counterfactual: what would have happened without the drug? Murphy et al., JVECC; primary abstract.
3. Penetrating cardiac injury: a useful case, not a survival estimate
Evidence: Single canine case report; published October 18, 2026. A dog with a suspected penetrating stick injury developed hemothorax and ongoing hemorrhage. Emergency thoracotomy identified a right ventricular defect that was directly repaired. The reported 90-day echocardiogram was unremarkable, and normal activity resumed.
What this means: This report demonstrates a possible successful course, not the probability of survival, the superiority of a technique, or a general diagnostic sequence for every unstable patient.
Study takeaway: As a clinical reasoning inference, persistent hemorrhage after penetrating chest trauma should keep deeper injury in the differential. A successful individual outcome is valuable for awareness but cannot replace cohort evidence. Graafland et al., Veterinary Record Case Reports; publisher summary.
Bottom line
A useful evidence summary explains both what happened and what the study design cannot tell us. Selected-case success, improvement during multiple treatments and a remarkable single recovery are not interchangeable forms of evidence.
Reading scope and primary sources
Source checks used accessible primary abstracts/publisher summaries. This is not a comprehensive systematic review. No dosage or treatment protocol is proposed.
Titles below are concise identifying titles, not verbatim full bibliographic titles; exact IDs resolve to publisher metadata. No claim of full-text review for all studies.
- Pyothorax management and outcomes: 103 cases
Study publication: 2026-10-13. Retrospective 65-dog/38-cat cohort. DOI: 10.1111/jsap.70214. - Acute feline CHF treated with pimobendan: 71 cases
Study publication: 2026-10-15. Retrospective single-centre cohort. DOI: 10.1111/vec.70173. - Penetrating chest/heart trauma in a dog
Study publication: 2026-10-18. Single case report. DOI: 10.1002/vrc2.70652.
DVMReady provides independent educational support. Verify current examination, licensing, and clinical information with the relevant official source and professional references.
Official Sources
Check current guidance against the original sources.